COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer
Colorectal cancer is currently the third most common cancer in Malaysia. Elevated expression of COX-2, an induced cyclooxygenase isoenzyme, has been seen in colonic adenomas and colorectal carcinoma. There is evidence that inhibition of this COX-2 can decrease the risk of colorectal cancer. Selectiv...
| Main Authors: | Ryan, A R, Rosita, A R, Khalid, Kamarul Ariffin, Qureshi, Akhtar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Malaysian Medical Association
1999
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/23984/ http://irep.iium.edu.my/23984/ http://irep.iium.edu.my/23984/1/COX-2_Inhibitors_-_A_Potential_Target_for_Drug_Therapy_in_the_Management_of_Colorectal_Cancer.pdf |
Similar Items
-
Potential of dihydropyrimidine dehydrogenase genotypes in personalising 5-fluorouracil therapy among colorectal cancer patients
by: Ngow, Harris Abdullah, et al.
Published: (2011) -
Antibody drug conjugate in cancer therapy
by: Bakhtiar, M. Taher
Published: (2019) -
Studies of Malaysian plants in prevention and treatment of colorectal cancer
by: Hashim, Yumi Zuhanis Has-Yun, et al.
Published: (2016) -
Colorectal cancer screening at primary care update
by: Shalihin, Mohd Shaiful Ehsan
Published: (2020) -
Assessment of ibuprofen, non-selective cox inhibitor, as a neuroprotective agent in Alzheimer’s model of rats
by: Saxena, Anil Kumar, et al.
Published: (2013)